Asarina Pharma Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
PIPE
- Latest Deal Amount
-
$4.9M
- Investors
-
6
Asarina Pharma General Information
Description
Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.
Contact Information
Website
www.asarinapharma.comCorporate Office
- Karolinska Institutet Science Park
- Fogdevreten 2
- 171 65 Solna
- Sweden
Corporate Office
- Karolinska Institutet Science Park
- Fogdevreten 2
- 171 65 Solna
- Sweden
Asarina Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. PIPE | 24-Oct-2019 | $4.9M | Completed | Generating Revenue | ||
| 6. Secondary Transaction - Private | 24-Oct-2019 | Completed | Generating Revenue | |||
| 5. IPO | 24-Sep-2018 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 07-Nov-2016 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 30-Apr-2014 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 13-Apr-2011 | $5.66M | $5.66M | Completed | Startup | |
| 1. Early Stage VC | Completed | Startup |
Asarina Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 329,170 | $6.74 | $6.74 | 1x | $6.74 | 18.47% | ||
| Ordinary | 267,500 | $6.74 | $6.74 | 1x | $6.74 | 15.01% |
Asarina Pharma Patents
Asarina Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020011789-A1 | Injectable suspensions | Inactive | 09-Jul-2018 | ||
| AU-2019249932-A1 | Gaba-a antagonists for treating substance withdrawal disorders | Inactive | 05-Apr-2018 | ||
| CA-3094026-A1 | Gaba-a antagonists for treating substance withdrawal disorders | Inactive | 05-Apr-2018 | ||
| EP-3773599-A1 | Gaba-a antagonists for treating substance withdrawal disorders | Inactive | 05-Apr-2018 | ||
| US-20210161915-A1 | Gaba-a antagonists for treating substance withdrawal disorders | Inactive | 05-Apr-2018 | A61K31/57 |
Asarina Pharma Signals
Asarina Pharma Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fjärde AP-fonden | Limited Partner | Minority | ||
| Svenska Handelsbanken | Corporation | Minority | ||
| Swedbank Robur | Asset Manager | Minority | ||
| Ergomed Group | PE-Backed Company | Minority | ||
| Rosetta Capital (UK) | Venture Capital | Minority |
Asarina Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Asarina Pharma FAQs
-
When was Asarina Pharma founded?
Asarina Pharma was founded in 2006.
-
Where is Asarina Pharma headquartered?
Asarina Pharma is headquartered in Solna, Sweden.
-
What is the size of Asarina Pharma?
Asarina Pharma has 7 total employees.
-
What industry is Asarina Pharma in?
Asarina Pharma’s primary industry is Drug Discovery.
-
Is Asarina Pharma a private or public company?
Asarina Pharma is a Private company.
-
What is Asarina Pharma’s current revenue?
The current revenue for Asarina Pharma is .
-
How much funding has Asarina Pharma raised over time?
Asarina Pharma has raised $36.5M.
-
Who are Asarina Pharma’s investors?
Fjärde AP-fonden, Svenska Handelsbanken, Swedbank Robur, Ergomed Group, and Rosetta Capital (UK) are 5 of 6 investors who have invested in Asarina Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process